Thus, while it is unclear how certain provisions of the IRA will be implemented, the IRA will likely have a significant impact on the pharmaceutical industry. It is unclear to what extent other statutory, regulatory, and administrative initiatives will be enacted and implemented, and to what extent these or any future legislation or regulations by the current administration or subsequent administrations will have on our business, including market acceptance, and sales, of our products and product candidates.
All entries for: BioAtla
May 6, 2025
BioAtla
Neutral Outlook
San Diego, CA
51-200 employees
Disease Area: Oncology
Drug Type: Biologic
March 28, 2025
BioAtla
Layoffs
San Diego, CA
51-200 employees
Looking to cut back on costs and streamline its structure, BioAtla is reducing its headcount by approximately 30%, according to an SEC filing on Thursday.
Disease Area: Oncology
Drug Type: Biologic